Mouse IL-1ra/IL-1F3 Antibody Summary
Applications
Mouse IL-1ra/IL-1F3 Sandwich Immunoassay
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
IL‑1ra/IL‑1F3 Inhibition of IL‑1 alpha /IL‑1F1-dependent Cell Proliferation and Neutralization by Mouse IL‑1ra/IL‑1F3 Antibody. Recombinant Mouse IL-1ra/IL-1F3 (Catalog # 480-RM) inhibits Recombinant Human IL-1a/IL-1F1 (Catalog # 200-LA) induced proliferation in the D10.G4.1 mouse helper T cell line in a dose-dependent manner (orange line). Inhibition of Recombinant Human IL-1a/IL-1F1 (50 pg/mL) activity elicited by Recombinant Mouse IL-1ra/IL-1F3 (150 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Mouse IL-1ra/IL-1F3 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-480-NA). The ND50 is typically 1-5 µg/mL.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-1ra/IL-1F3
IL-1ra was originally isolated from the urine of patients with monocytic leukemia and has also been purified from adherent monocytes. The naturally-occurring, fully glycosylated form has an apparent molecular weight of about 25,000 Daltons. The protein shows 26% amino acid homology to IL-1 beta and 19% homology to IL-1 alpha. It will compete with either factor for receptor binding, but does not interact with either one. Human IL-1ra will bind to both types of IL-1 receptor (I and II) on human cells. In mouse, IL-1 RII does not bind IL-1ra. The recombinant, non-glycosylated form of IL-1ra blocks binding of IL-1 to its receptor equally as well as the naturally-occurring, glycosylated form. The IL-1ra has been shown to block the inflammatory responses induced by IL-1 both in vitro and in vivo. Pre-clinical and clinical studies were done to test possible therapeutic applications for IL-1ra in the treatment of sepsis, rheumatoid arthritis and chronic myelogenous leukemia.
Product Datasheets
Citations for Mouse IL-1ra/IL-1F3 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
10
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing
Authors: Y Zheng, X Dong, S Chen, Y He, J An, M Liu, L He, Y Zhang
BMC Oral Health, 2023-01-10;23(1):14.
Species: Mouse
Sample Types: In Vivo
Applications: Neutralization -
Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke
Authors: CU von Linsto, SM Hindkjær, PV Nielsen, M Degn, KL Lambertsen, B Finsen, BH Clausen
Cells, 2021-04-20;10(4):.
Species: Mouse
Sample Types: Whole Cells
Applications: ICC -
Effective combinatorial immunotherapy for castration-resistant prostate cancer
Authors: X Lu, JW Horner, E Paul, X Shang, P Troncoso, P Deng, S Jiang, Q Chang, DJ Spring, P Sharma, JA Zebala, DY Maeda, YA Wang, RA DePinho
Nature, 2017-03-20;543(7647):728-732.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization -
Correction: Yersinia pestis Activates Both IL-1beta and IL-1 Receptor Antagonist to Modulate Lung Inflammation during Pneumonic Plague.
PLoS Pathog, 2015-05-13;11(5):e1004921.
Species: Mouse
Sample Types: In Vivo
-
Brain interleukin-1beta and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats.
Authors: Yamato M, Tamura Y, Eguchi A, Kume S, Miyashige Y, Nakano M, Watanabe Y, Kataoka Y
PLoS ONE, 2014-03-12;9(3):e90950.
Species: Rat
Sample Types: In Vivo, Protein
Applications: Neutralization, Western Blot -
Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis.
Authors: Osuchowski MF, Connett J, Welch K, Granger J, Remick DG
Crit. Care Med., 2009-05-01;37(5):1567-73.
Species: Mouse
Sample Types: Plasma
Applications: ELISA Development -
Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury.
Authors: Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG
Proc. Natl. Acad. Sci. U.S.A., 2007-06-14;104(26):11002-7.
Species: Mouse
Sample Types: Whole Cells
Applications: Neutralization -
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.
Authors: Osuchowski MF, Welch K, Siddiqui J, Remick DG
J. Immunol., 2006-08-01;177(3):1967-74.
Species: Mouse
Sample Types: Plasma
Applications: ELISA Development -
Sequential ELISA to profile multiple cytokines from small volumes.
Authors: Osuchowski MF, Siddiqui J, Copeland S, Remick DG
J. Immunol. Methods, 2005-07-01;302(1):172-81.
Species: Mouse
Sample Types: Plasma
Applications: ELISA Development -
Ibuprofen protects ischemia-induced neuronal injury via up-regulating interleukin-1 receptor antagonist expression.
Authors: Park EM, Cho BP, Volpe BT, Cruz MO, Joh TH, Cho S
Neuroscience, 2005-01-01;132(3):625-31.
Species: Rat
Sample Types: Whole Cells, Whole Tissue
Applications: IHC-Fr, Neutralization
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Mouse IL-1ra/IL-1F3 Antibody
There are currently no reviews for this product. Be the first to review Mouse IL-1ra/IL-1F3 Antibody and earn rewards!
Have you used Mouse IL-1ra/IL-1F3 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image